Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Leonardo, Flenghi"'
Autor:
Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Daniele Sorcini, Stelvio Ballanti, Leonardo Flenghi, Nicodemo Baffa, Piero Covarelli, Paolo Sportoletti, Antonio Pierini, Brunangelo Falini
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 559-562 (2023)
Externí odkaz:
https://doaj.org/article/4e87b8e91a274514b1d4752d200c255c
Autor:
Robel Papotti, Filippo Vit, Federico Pozzo, Tamara Bittolo, Stefania Bettelli, Samantha Pozzi, Antonino Maiorana, Elisa Forti, Arianna DI Napoli, Maria Christina Cox, Tamar Tadmor, Giovanna Mansueto, Pellegrino Musto, Leonardo Flenghi, Martina Quintini, Vittoria Lalinga, Sara Galimberti, Valentina Donati, Michele Spina, Alberto Zamò, Andreas Rosenwald, Riccardo Bomben, Stefano Sacchi, Valter Gattei
Publikováno v:
HemaSphere, Vol 7, p e8756390 (2023)
Externí odkaz:
https://doaj.org/article/cc7ce7e2c97b4c88b0af373d384b59a1
Autor:
Lisa Argnani, Alessandro Broccoli, Cinzia Pellegrini, Alberto Fabbri, Benedetta Puccini, Riccardo Bruna, Maria Chiara Tisi, Francesco Masia, Leonardo Flenghi, Maria Elena Nizzoli, Maurizio Musso, Marilena Salerno, Potito Rosario Scalzulli, Daniela Dessi’, Isacco Ferrarini, Elsa Pennese, Elisa Lucchini, Francesca Gaia Rossi, Carla Minoia, Filippo Gherlinzoni, Pellegrino Musto, Caterina Patti, Vittorio Stefoni, Pier Luigi Zinzani
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e798 (2022)
After FDA and EMA approval of the regimen containing polatuzumab vedotin plus rituximab and bendamustine (PolaBR), eligible relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients in Italy were granted early access through a Named Patient
Externí odkaz:
https://doaj.org/article/1cc1af983bd1486091a4adbd8c7747a9
Autor:
Alessandra Tucci, Francesco Merli, Alberto Fabbri, Luigi Marcheselli, Chiara Pagani, Benedetta Puccini, Dario Marino, Manuela Zanni, Elsa Pennese, Leonardo Flenghi, Annalisa Arcari, Barbara Botto, Melania Celli, Caterina Mammi, Alessandro Re, Giulia Campostrini, Agostino Tafuri, Vittorio R. Zilioli, Emanuele Cencini, Roberto Sartori, Chiara Bottelli, Michele Merli, Luigi Petrucci, Guido Gini, Monica Balzarotti, Federica Cavallo, Gerardo Musuraca, Stefano Luminari, Giuseppe Rossi, Michele Spina
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Octogenarian patients with diffuse large B-cell lymphoma are managed mainly with palliation, but recent improvement in their overall condition makes potentially curative treatment a possibility. Studies have shown that half of selected octogenarians
Externí odkaz:
https://doaj.org/article/12dfe59dc2684c01b9933e3cf71feb85
Autor:
Simonetta Saldi, Vincenzo Maria Perriello, Lorenza Falini, Loredana Ruggeri, Christian Fulcheri, Sara Ciardelli, Alessandra Innocente, Stelvio Ballanti, Nicodemo Baffa, Leonardo Flenghi, Antonio Pierini, Cynthia Aristei, Brunangelo Falini
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
CAR T cell therapy has transformed the salvage approach for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). Maintaining disease control before CAR T cell infusion during product manufacturing (so-called bridging therapy) is an importan
Externí odkaz:
https://doaj.org/article/f4a02128c9a64673ad858fda0012544e
Autor:
Annalisa Arcari, Valentina Tabanelli, Francesco Merli, Luigi Marcheselli, Michele Merli, Monica Balzarotti, Vittorio Ruggero Zilioli, Alberto Fabbri, Federica Cavallo, Gloria Margiotta Casaluci, Alessandra Tucci, Benedetta Puccini, Elsa Pennese, Alice Di Rocco, Manuela Zanni, Leonardo Flenghi, Guido Gini, Roberto Sartori, Annalisa Chiappella, Sara Veronica Usai, Monica Tani, Dario Marino, Luca Arcaini, Daniele Vallisa, Michele Spina
Publikováno v:
British Journal of Haematology. 201:653-662
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea26569402dfcbba630833fe86c83f9
https://doi.org/10.1111/bjh.18678
https://doi.org/10.1111/bjh.18678
Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas
Autor:
Laura Caruso, Alessia Castellino, Daniela Dessì, Leonardo Flenghi, Antonio Giordano, Adalberto Ibatici, Cesare Massone, Alessandro Pileri, Ilaria Proietti, Livio Pupo, Pietro Quaglino, Serena Rupoli, Pier Luigi Zinzani
Publikováno v:
Cancer Management and Research. 14:3205-3221
Laura Caruso,1 Alessia Castellino,2 Daniela Dessì,3 Leonardo Flenghi,4 Antonio Giordano,5 Adalberto Ibatici,6 Cesare Massone,7 Alessandro Pileri,8 Ilaria Proietti,9 Livio Pupo,10 Pietro Quaglino,11 Serena Rupoli,12 Pier Luigi Zinzani13,14 1Hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b47cb83a3f4415a85f156e65f3b0562
https://doi.org/10.2147/cmar.s377015
https://doi.org/10.2147/cmar.s377015
Autor:
Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, Cristina Tecchio, Giuseppe Carli, Mattia Novo, Piero Maria Stefani, Sara Rattotti, Monica Balzarotti, Dario Marino, Matteo Pelosini, Alessandra Romano, Leonardo Flenghi, Vittorio Ruggero Zilioli, Teresa Calimeri, Arianna Di Napoli, Manuela Zanni, Erica Finolezzi, Federico Mosna, Guido Gini, Giovanna Mansueto, Alice Di Rocco, Gabriella Tomei, Nicola Sgherza, Jacopo Olivieri, Luca Nassi, Francesco Piazza, Angelo Fama, Antonio Greco, Margherita Giannoccaro, Anna Maria Mazzone, Carlo Visco, Giacomo Loseto, Francesco Zaja, on behalf of the Fondazione Italiana Linfomi Postgraduate Master course
Publikováno v:
HemaSphere, Vol 3, Iss 6, p e305 (2019)
Externí odkaz:
https://doaj.org/article/c5076ec0c55c45bb92e7e1bb6168a470
Autor:
Luigi Rigacci, Roberta Battistini, Sofia Kovalchuk, Valerio Zoli, Benedetta Puccini, Andrea Evangelista, Luca Arcaini, Leonardo Flenghi, Carlo Visco, Michael Mian, Alice Di Rocco, Claudia Peracchio, Manuel Gotti, Maria Chiara Tisi, Francesca Palombi, Samantha Pozzi, Daniela Gioia, Piera Viero, Maurizio Martelli
Publikováno v:
Hematological Oncology. 40:609-616
Salvage immunochemotherapy and transplant consolidation is the standard treatment for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL). We tested a combination of Obinutuzumab and DHAP for treating R/R DLBCL. The primary end point w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8712f0929a08832d12510bbc132946
https://doi.org/10.1002/hon.3028
https://doi.org/10.1002/hon.3028
Autor:
Anna Ferrari, Silvia Arniani, Barbara Crescenzi, Stefano Ascani, Leonardo Flenghi, Valentina Pierini, Martina Moretti, Donatella Beacci, Silvia Romoli, Valentina Bardelli, Daniele Calistri, Giovanni Martinelli, Cristina Mecucci, Roberta La Starza
Publikováno v:
Leukemia & Lymphoma. 63:1356-1362
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d99ef513beb2829d3d1b084624a37358
https://doi.org/10.1080/10428194.2021.2024821
https://doi.org/10.1080/10428194.2021.2024821